Clinical Trial Update: Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating doxepin hydrochloride for oral mucositis pain in patients with head and neck cancer undergoing radiation therapy with or without chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Oral Mucositis

Drugs mentioned

• DOXEPIN HYDROCHLORIDE (doxepin hydrochloride)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Head and Neck Cancer, Mucositis | Phase 3 | Status: COMPLETED | Results posted: 2017-05-08